These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 19240067)

  • 1. Sudden death: hypertrophic cardiomyopathy with myocardial scarring and extremely rare coronary origin.
    Zuccarino F; Moral S; Pujol E
    Eur Heart J; 2009 Jun; 30(11):1355. PubMed ID: 19240067
    [No Abstract]   [Full Text] [Related]  

  • 2. Extensive scar myocardium in hypertrophic cardiomyopathy with severe myocardial bridge.
    Cheng MF; Wu YW; Liu YB; Huang PJ; Tzen KY; Yen RF
    Int J Cardiol; 2007 Feb; 115(3):e105-7. PubMed ID: 17049644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk assessment with cardiac magnetic resonance imaging in hypertrophic cardiomyopathy.
    Gosling OE; Bellenger N; Spurrell P
    Heart; 2009 Nov; 95(22):1843. PubMed ID: 19875370
    [No Abstract]   [Full Text] [Related]  

  • 4. Noninvasive risk stratification prevents sudden death due to paroxysmal atrial fibrillation in hypertrophic cardiomyopathy.
    Limongelli G; Elliott PM; Pacileo G; Sarubbi B; Thaman R; Calabrò P; Vergara P; Iacomino M; Russo MG; Calabrò R
    J Cardiovasc Med (Hagerstown); 2006 Sep; 7(9):711-3. PubMed ID: 16932087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sudden cardiac death in athletes.
    Tripathi BK; Gupta B; Agarwal AK
    J Assoc Physicians India; 2001 Jun; 49():643-9. PubMed ID: 11584942
    [No Abstract]   [Full Text] [Related]  

  • 6. Study of sudden cardiac deaths in young athletes.
    Kahali B; Roy DG; Batabyal S; Bose TK
    J Indian Med Assoc; 2002 Dec; 100(12):708-9. PubMed ID: 12793636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duplication of the right coronary artery in a patient with hypertrophic cardiomyopathy and myocardial bridging.
    Ciftci H; Tacoy G; Yazici G
    Cardiol Young; 2009 Dec; 19(6):627-9. PubMed ID: 19825248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sudden cardiac death in young athletes: trying to find the needle in the haystack.
    Ng B; Maginot KR
    WMJ; 2007 Sep; 106(6):335-42. PubMed ID: 17970016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. QT dispersion and myocardial bridging.
    Kasikcioglu E
    Int J Cardiol; 2005 Jul; 102(3):523. PubMed ID: 16004901
    [No Abstract]   [Full Text] [Related]  

  • 10. A rare variant of single coronary artery and non-obstructive hypertrophic cardiomyopathy.
    Atmaca Y; Dandachi R; Oral D
    J Invasive Cardiol; 2002 Aug; 14(8):469-70. PubMed ID: 12147880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Congenital coronary artery abnormalities predisposing to sudden cardiac death.
    Frommelt PC
    Pacing Clin Electrophysiol; 2009 Jul; 32 Suppl 2():S63-6. PubMed ID: 19602166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of sudden cardiac death in young athletes: which screening strategies are appropriate?
    Bader RS; Goldberg L; Sahn DJ
    Pediatr Clin North Am; 2004 Oct; 51(5):1421-41. PubMed ID: 15331292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symptomatic myocardial bridging in a child without hypertrophic cardiomyopathy.
    Daana M; Wexler I; Milgalter E; Rein AJ; Perles Z
    Pediatrics; 2006 Feb; 117(2):e333-5. PubMed ID: 16390919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-modality imaging in an exceptional case of aborted sudden cardiac death.
    Sonck J; Tanaka K; Czapla J; Vanderhasselt T; Kayaert P; Scott B; Sutherland G; Van Camp G
    Int J Cardiol; 2014 Feb; 171(2):e57-8. PubMed ID: 24365616
    [No Abstract]   [Full Text] [Related]  

  • 15. Hypertrophic cardiomyopathy: ask athletes these 9 questions.
    deWeber K; Beutler A
    J Fam Pract; 2009 Nov; 58(11):576-84. PubMed ID: 19891935
    [No Abstract]   [Full Text] [Related]  

  • 16. Primary prevention of sudden death as a novel treatment strategy in hypertrophic cardiomyopathy.
    Maron BJ; Estes NA; Maron MS; Almquist AK; Link MS; Udelson JE
    Circulation; 2003 Jun; 107(23):2872-5. PubMed ID: 12814983
    [No Abstract]   [Full Text] [Related]  

  • 17. Myocardial bridging in adult and pediatric patients with hypertrophic cardiomyopathy is not associated with poor outcome.
    Mohiddin SA; Fananapazir L
    J Am Coll Cardiol; 2004 Mar; 43(6):1133; author reply 1133. PubMed ID: 15028383
    [No Abstract]   [Full Text] [Related]  

  • 18. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: is it safe?
    Veselka J
    Catheter Cardiovasc Interv; 2009 Sep; 74(3):520-1; author reply 522. PubMed ID: 19496117
    [No Abstract]   [Full Text] [Related]  

  • 19. Myocardial bridging, a frequent component of the hypertrophic cardiomyopathy phenotype, lacks systematic association with sudden cardiac death.
    Basso C; Thiene G; Mackey-Bojack S; Frigo AC; Corrado D; Maron BJ
    Eur Heart J; 2009 Jul; 30(13):1627-34. PubMed ID: 19406869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extensive myocardial fibrosis in a patient with hypertrophic cardiomyopathy and ventricular tachycardia without traditional high-risk features.
    Bongioanni S; Spirito P; Masi AS; Chiribiri A; Bonamini R; Conte MR
    Circ Cardiovasc Imaging; 2009 Jul; 2(4):349-50. PubMed ID: 19808616
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.